Skip to main content
. 2013 Oct 30;2013:317456. doi: 10.1155/2013/317456

Figure 5.

Figure 5

Representative immunoprecipitated and summary data of P-GSK-3β/VDAC and GSK-3β/VDAC associations in cytosolic fraction from nonischemic control (NIC), ischemic control (IC), preconditioned (PRE), postconditioned (POS), PRE + W (wortmannin), POS + W, lithium, and IMI treated hearts. These data show that the P-GSK-3β/VDAC association was minimal in IC hearts and maximal in hearts treated with GSK-3β inhibitors. W decreased significantly the P-GSK-3β/VDAC association detected in PRE and POS. *P < 0.05 versus NIC; # P < 0.05 versus IC; ξ P < 0.05 versus PRE and POS.